Business Context and Reporting Period
Company: Primedex Health Systems, Inc. (Note: Metadata referenced Radnet, Inc., but the filing is for Primedex Health Systems, Inc., which operates Radnet facilities).
Reporting Period: Quarter ended January 31, 2002 (Form 10-Q).
Business Overview: The Company provides diagnostic imaging services (MRI, CT, PET, ultrasound, mammography, nuclear medicine) through 48 facilities in California. Operations include Radnet Management, Inc. and Diagnostic Imaging Services, Inc., with medical services often provided through affiliated physician groups.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Net Revenue | $32,441,000 | $24,110,000 |
| Income from Operations | $4,337,000 | $4,213,000 |
| Net Income | $917,000 | $923,000 |
| EPS (Diluted) | $0.02 | $0.02 |
| Cash Flow from Operations | $5,460,000 | $1,578,000 |
| Cash and Equivalents (End of Period) | $3,000 | $21,000 |
| Total Debt (Current + Long-Term) | $116,734,000 | $110,188,000 (Long-term only listed) |
| Working Capital | ($29,827,000) Deficit | ($26,987,000) Deficit |
| Stockholders' Deficit | ($44,455,000) | ($45,642,000) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 34.6% ($8.3M) year-over-year. This was driven by the addition of eight new sites, new contracts, and renegotiated rates, partially offset by the prior year's sale of the VROC facility.
- Expense Increases: Total operating expenses rose 41.2% ($8.2M), primarily due to the expansion of facilities and variable costs associated with higher revenue. The provision for bad debts increased 79.6% to $1.2M.
- Profitability: Despite significant revenue growth, Net Income remained flat ($917k vs $923k) due to higher operating expenses and increased interest expense (up 13.8% to $3.8M).
- Liquidity Deterioration: Cash on hand dropped to $3,000. The working capital deficit widened by $2.8M to $29.8M, and the stockholders' deficit remained substantial at $44.5M.
- Accounting Change: Adoption of SFAS No. 142 (Goodwill) eliminated goodwill amortization, increasing income by approximately $375,000 for the quarter.
Outlook, Risks, and Management Commentary
- Liquidity Risk: Management explicitly states the financial statements are prepared assuming a "going concern" but highlights a significant working capital deficit. The Company relies on renegotiating debt terms and extending payment schedules to maintain operations.
- Strategic Initiatives: Plans include opening new centers (e.g., Rancho Bernardo, Tarzana), renegotiating managed care contracts (e.g., Primecare Medical Group capitation deal), and eliminating underperforming contracts.
- Debt Management: The Company is actively renegotiating notes with lenders (including DVI and GE) to extend terms and reduce monthly payments. Future debt obligations over the next five years are estimated at over $160M excluding lines of credit.
- Forward-Looking Risks: Success depends on adequate financial resources, favorable reimbursement rates, and the ability to fund development. Management notes that results are not necessarily indicative of full-year performance.
Investor Verification Checklist
- Cash Position: Verify the sustainability of operations with only $3,000 in cash and a $29.8M working capital deficit.
- Debt Covenants: Confirm the status of ongoing renegotiations with major lenders (DVI, GE) and the risk of default or forced restructuring.
- Revenue Quality: Assess the impact of the new Primecare capitation contract on future margins and the stability of the 150% revenue spike at the Temecula facility.
- Related Party Transactions: Review the $1.3M+ in notes payable to related parties and the forgiveness of $21k in debt/interest to a prior officer.
- Goodwill Impairment: Monitor future annual impairment tests for the $24M in net goodwill, as the company no longer amortizes this asset.